Gene: SCYGR7
Official Full Name: small cysteine and glycine repeat containing 7provided by HGNC
Gene Summary: Predicted to be located in intermediate filament. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14283 | SCYGR7 Knockout cell line (HeLa) | Human | SCYGR7 | 1:3~1:6 | Negative | Online Inquiry |
KO14284 | SCYGR7 Knockout cell line (HCT 116) | Human | SCYGR7 | 1:2~1:4 | Negative | Online Inquiry |
KO14285 | SCYGR7 Knockout cell line (A549) | Human | SCYGR7 | 1:3~1:4 | Negative | Online Inquiry |
SCYGR7 Gene Knockout Cell Lines are meticulously developed cellular models engineered to facilitate the investigation of the SCYGR7 gene's function within various biological processes. These cell lines are created through advanced CRISPR/Cas9 gene-editing technology, resulting in the complete disruption of the SCYGR7 gene. This knockout enables researchers to study the gene's role in cellular mechanisms, signaling pathways, and disease models, providing invaluable insights into its biological significance.
The primary mechanism behind these cell lines is the precise targeting and editing of the SCYGR7 genomic locus, leading to the generation of loss-of-function mutations. By analyzing the phenotypic changes and functional impairments associated with SCYGR7 loss, scientists can elucidate its contribution to critical cellular processes such as proliferation, differentiation, and apoptosis. These studies are essential in understanding not only the gene’s basic biology but also its potential implications in disease states, particularly in cancer research and therapeutic development.
The scientific importance of SCYGR7 Gene Knockout Cell Lines extends into both basic and applied research settings. Their utility in drug discovery, biomarker identification, and pathway analysis positions them as a crucial tool for academic and pharmaceutical researchers alike. Compared to alternative models, such as RNA interference-based approaches, these knockout cell lines provide a more stable and complete loss of gene function, resulting in more definitive experimental outcomes.
The unique selling points of SCYGR7 Gene Knockout Cell Lines lie in their reliability, reproducibility, and the speed with which researchers can obtain results. By utilizing these cell lines, researchers can achieve a deeper understanding of gene function and disease mechanisms, ultimately aiding in the development of innovative therapeutic strategies.
In summary, SCYGR7 Gene Knockout Cell Lines stand as a testament to our commitment to advancing biomedical research. Our experience in developing high-quality biological products ensures that researchers and clinicians are equipped with the tools necessary to explore pivotal biological questions with confidence and precision.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.